Featured Research

from universities, journals, and other organizations

Molecule that could treat inflammation discovered

Date:
July 10, 2012
Source:
North Shore-Long Island Jewish (LIJ) Health System
Summary:
Researchers have discovered that inflammation could be treated by targeting a molecule called the double-stranded RNA dependent protein kinase (PKR). Persistent and constant inflammation can damage tissue and organs, and lead to diseases such as sepsis, rheumatoid arthritis, and even cancer.

Researchers at The Feinstein Institute for Medical Research have discovered that inflammation could be treated by targeting a molecule called the double-stranded RNA dependent protein kinase (PKR). These findings were recently published in the journal Nature.

"Inflammation is necessary for maintaining good health, but when unchecked, it can play a part in a wide array of human diseases, such as arthritis, colitis and sepsis," said Scott Somers, PhD, who oversees inflammation grants at the National Institutes of Health (NIH), which partly supported the study. "By identifying a protein that controls a single aspect of inflammation, this work offers a new way to target the harmful effects of chronic inflammation while preserving the body's overall protective mechanisms."

The inflammasome is protein complex in cells that provides immediate defense against infection. It is found in all classes of plant and animal life and is fundamental in regulating the activation process of inflammation. Without inflammation, wounds and infections would never heal. However, persistent and constant inflammation can damage tissue and organs, and lead to diseases such as sepsis, rheumatoid arthritis, and even cancer. Therefore, it is important to identify ways in which persistent and constant inflammation can be halted.

In studying inflammation, Feinstein Institute researchers discovered that double-stranded RNA dependent protein kinase (PKR), a molecule not previously linked to the inflammasome, plays a critical role in inflammasome activation. Further, they found that targeting this molecule could treat inflammation.

"We are particularly interested in this discovery because it provides a new way to make novel drugs to treat obesity, Alzheimer's disease, diabetes, atherosclerosis and a host of other diseases." Noted Kevin J. Tracey, MD, president of the Feinstein Institute, and lead investigator of the study, which was funded by the NIH institutes the National Institute of General Medical Sciences and the National Institute of Diabetes and Digestive and Kidney Diseases -- the grant numbers are GM062508 and DK052539.


Story Source:

The above story is based on materials provided by North Shore-Long Island Jewish (LIJ) Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ben Lu, Takahisa Nakamura, Karen Inouye, Jianhua Li, Yiting Tang, Peter Lundbδck, Sergio I. Valdes-Ferrer, Peder S. Olofsson, Thomas Kalb, Jesse Roth, Yongrui Zou, Helena Erlandsson-Harris, Huan Yang, Jenny P.-Y. Ting, Haichao Wang, Ulf Andersson, Daniel J. Antoine, Sangeeta S. Chavan, Gφkhan S. Hotamisligil, Kevin J. Tracey. Novel role of PKR in inflammasome activation and HMGB1 release. Nature, 2012; DOI: 10.1038/nature11290

Cite This Page:

North Shore-Long Island Jewish (LIJ) Health System. "Molecule that could treat inflammation discovered." ScienceDaily. ScienceDaily, 10 July 2012. <www.sciencedaily.com/releases/2012/07/120710120337.htm>.
North Shore-Long Island Jewish (LIJ) Health System. (2012, July 10). Molecule that could treat inflammation discovered. ScienceDaily. Retrieved August 31, 2014 from www.sciencedaily.com/releases/2012/07/120710120337.htm
North Shore-Long Island Jewish (LIJ) Health System. "Molecule that could treat inflammation discovered." ScienceDaily. www.sciencedaily.com/releases/2012/07/120710120337.htm (accessed August 31, 2014).

Share This




More Health & Medicine News

Sunday, August 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) — A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) — Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) — California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) — Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins